Cell-based implant offers new hope for diabetes management, Technion study shows

Feb 8, 2026 8:49 am | Jpost

Technion–Israel Institute of Technology (photo credit: Wikimedia Commons)
The study, which is peer-reviewed and published in Science introduces a “living, cell-based implant” that works as a pancreas and is protected against immune rejection by a novel system.
|  Read More  JPost.com – The Jerusalem Post – All News from the Middle East, Israel, and the Jewish World 

0 Comments

FREE ISRAEL DAILY EMAIL!

BREAKING NEWS

JNS